##### Table of Contents



SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-QSB
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D)
OF THE SECURITIES EXCHANGE ACT OF 1934
  o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D)
OF THE SECURITIES EXCHANGE ACT OF 1934
   SUTURA, INC.
  
 Delaware
    
    84-1010269(State or other jurisdiction of 
incorporation or organization)
    
    (I.R.S. Employer Identification No.)
 
   
  þ o
 
 o o þ
  o þ
  o þ




---



##### Table of Contents



PART I
 Item 1.
    
    Financial StatementsConsolidated Balance Sheet on June 30, 2007 (Unaudited)Consolidated Statement of Operations for the three and six month periods ended June 30, 2007 and 2006 (Unaudited)Consolidated Statement of Cash Flows for the six month periods ended June 30, 2007 and 2006(Unaudited)Notes to Consolidated Financial Statements (Unaudited)Item 2.
    
    Managements Discussion and Analysis of Financial Condition and Results of OperationsItem 3.
    
    Controls and ProceduresPART IIItem 1.
    
    Legal ProceedingsItem 2.
    
    Changes In SecuritiesItem 3.
    
    Defaults Upon Senior SecuritiesItem 4.
    
    Submission of Matters to a Vote of Security HoldersItem 5.
    
    Other InformationItem 6.
    
    Exhibits and Reports on Form 8-KSignaturesEXHIBIT 10.45EXHIBIT 10.46EXHIBIT 10.47EXHIBIT 10.48EXHIBIT 10.49EXHIBIT 31.1EXHIBIT 31.2EXHIBIT 32.1




---



##### Table of Contents



PART I: FINANCIAL INFORMATION
 
 Item 1.
    
    Financial Statement
 
 
 2007ASSETSCURRENT ASSETS:Cash & cash equivalents
    
    $
    30,388Accounts Receivable, Net
    
    
    111,169Inventory
    
    
    428,827Prepaid expenses
    
    
    65,368Total current assets
    
    
    635,752PROPERTY AND EQUIPMENT, net
    
    
    345,631DEPOSITS
    
    
    168,165$
    1,149,548LIABILITIES AND STOCKHOLDERS DEFICITCURRENT LIABILITIES:Accounts payable and accrued expenses
    
    $
    4,077,779Loan payable  officers
    
    
    116,928Customer deposits
    
    
    1,116,850Notes payable  officers
    
    
    926,408Notes payable  related party
    
    
    148,204Convertible notes payable- net of beneficial conversion feature
    
    
    2,253,717Total current liabilities
    
    
    8,639,886LONG TERM LIABILITIES:Convertible notes payable- net of beneficial conversion feature
    
    
    17,385,400COMMITMENTS AND CONTINGENCIES
    
    
    STOCKHOLDERS DEFICITSeries A convertible preferred stock, $0.001 par value;
2,000,000 shares authorized, none issued and outstanding
    
    
    Common stock, $0.001 par value; 500,000,000 shares authorized;
271,229,807 shares issued and outstanding
    
    
    271,230Additional paid in capital
    
    
    50,173,810Accumulated deficit
    
    
    (74,372,842
    )Other comprehensive loss
    
    
    (947,934
    )Total stockholders deficit
    
    
    (24,875,737
    )$
    1,149,548




---



##### Table of Contents



THREE MONTHS
    
    
    THREE MONTHS
    
    
    SIX MONTHS
    
    
    SIX MONTHS2007
    
    
    2006
    
    
    2007
    
    
    2006NET SALES
    
    $
    57,362
    
    
    $
    153,689
    
    
    $
    138,978
    
    
    $
    396,800COST OF GOODS SOLD(1)
    
    
    425,258
    
    
    
    428,399
    
    
    
    907,575
    
    
    
    1,053,680GROSS LOSS
    
    
    (367,897
    )
    
    
    (274,710
    )
    
    
    (768,597
    )
    
    
    (656,881
    )OPERATING EXPENSES:Research and development(1)
    
    
    114,157
    
    
    
    145,701
    
    
    
    276,748
    
    
    
    272,607General and administrative(1)
    
    
    991,775
    
    
    
    1,029,338
    
    
    
    2,183,160
    
    
    
    2,443,028Sales and marketing(1)
    
    
    181,163
    
    
    
    518,453
    
    
    
    334,422
    
    
    
    993,917Total operating expenses
    
    
    1,287,096
    
    
    
    1,693,492
    
    
    
    2,794,330
    
    
    
    3,709,551OPERATING LOSS
    
    
    (1,654,992
    )
    
    
    (1,968,202
    )
    
    
    (3,562,927
    )
    
    
    (4,366,432
    )OTHER INCOME (EXPENSE)Interest Income
    
    
    1,504
    
    
    
    772
    
    
    
    8,440
    
    
    
    14,828Interest Expense(2)
    
    
    (1,112,443
    )
    
    
    (877,662
    )
    
    
    (2,183,668
    )
    
    
    (2,042,258
    )Other Income (Expense)
    
    
    0
    
    
    
    0
    
    
    
    0
    
    
    
    0Total other income(expense), net
    
    
    (1,110,938
    )
    
    
    (876,890
    )
    
    
    (2,175,228
    )
    
    
    (2,027,430
    )NET LOSS
    
    
    (2,765,931
    )
    
    
    (2,845,090
    )
    
    
    (5,738,155
    )
    
    
    (6,393,862
    )OTHER COMPREHENSIVE GAIN (LOSS)Translation adjustment
    
    
    (2,520
    )
    
    
    1,128
    
    
    
    (10,770
    )
    
    
    (10,773
    )COMPREHENSIVE LOSS
    
    $
    (2,768,451
    )
    
    $
    (2,843,964
    )
    
    $
    (5,748,925
    )
    
    $
    (6,404,635
    )BASIC AND DILUTED NET LOSS PER SHARE
    
    $
    (0.01
    )
    
    $
    (0.02
    )
    
    $
    (0.02
    )
    
    $
    (0.03
    )BASIC AND DILUTED WEIGHTED AVERAGE
    
    
    268,188,599
    
    
    
    186,637,990
    
    
    
    262,157,278
    
    
    
    186,031,080SHARES OUTSTANDING**Weighted average number of shares used to compute basic and diluted loss per share
is the same since the effect of dilutive securities is anti-dilutive.The accompanying notes are an integral part of these consolidated financial statements.(1) Includes stock-based compensation charges (credits) of:Cost of good sold
    
    $
    15,128
    
    
    $
    15,797
    
    
    $
    30,256
    
    
    $
    101,888Research and development
    
    
    14,208
    
    
    
    16,717
    
    
    
    28,416
    
    
    
    33,434General and administrative
    
    
    49,115
    
    
    
    46,314
    
    
    
    98,230
    
    
    
    418,062Sales and Marketing
    
    
    4,181
    
    
    
    21,408
    
    
    
    8,362
    
    
    
    68,851(2) Includes amortization of beneficial conversion
feature and warrants issued of:
    
    $
    580,657
    
    
    $
    148,128
    
    
    $
    1,150,606
    
    
    $
    868,631




---



##### Table of Contents



2007
    
    
    2006CASH FLOWS FROM OPERATING ACTIVITIES:Net loss
    
    $
    (5,738,155
    )
    
    $
    (6,393,862
    )Adjustments to reconcile net loss to net cash used
in operating activities:Depreciation and amortization
    
    
    115,560
    
    
    
    137,534Beneficial conversion feature
    
    
    1,150,606
    
    
    
    1,168,580Stock based compensation expenses- employees
    
    
    165,264
    
    
    
    622,235Stock based compensation expenses- non employees
    
    
    76,366
    
    
    
    52,212Interest expenses converted into shares.
    
    
    959,667
    
    
    
    (Increase) decrease in current assets:Accounts receivables
    
    
    (20,990
    )
    
    
    (57,512
    )Inventory
    
    
    28,174
    
    
    
    (314,069
    )Prepaid expenses
    
    
    17,117
    
    
    
    70,484Increase (decrease) in current liabilities:Accounts payable and accrued liabilities
    
    
    48,907
    
    
    
    1,190,275Accrued payroll
    
    
    (4,914
    )
    
    
    (68,966
    )Customer deposits
    
    
    (23,125
    )
    
    
    (5,000
    )Total Adjustments
    
    
    2,512,631
    
    
    
    2,795,773Net cash used for operating activities
    
    
    (3,225,524
    )
    
    
    (3,598,089
    )CASH FLOWS INVESTING ACTIVITIES:Acquisition of property and equipment, net
    
    
    (39,018
    )
    
    
    (132,297
    )CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from notes payable
    
    
    2,050,000
    
    
    
    1,750,000Effect of rate changes on cash and cash equivalents
    
    
    6,774
    
    
    
    2,751NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS
    
    
    (1,207,768
    )
    
    
    (1,980,386
    )CASH & CASH EQUIVALENTS, BEGINNING BALANCE
    
    
    1,238,154
    
    
    
    2,317,003CASH & CASH EQUIVALENTS, ENDING BALANCE
    
    $
    30,388
    
    
    $
    339,368SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:Interest paid
    
    $
    
    
    
    $
    Income taxes
    
    $
    
    
    
    $
    




---



##### Table of Contents








---



##### Table of Contents








---



##### Table of Contents








---



##### Table of Contents



,
  . .




---



##### Table of Contents



AggegrateWeighted
    
    
    IntrinsicTotal
    
    
    price
    
    
    ValueOUTSTANDING, DECEMBER 31, 2006
    
    
    42,617,899
    
    
    $
    0.103Granted in 2007
    
    
    2,300,000
    
    
    $
    0.0700Cancelled in 2007
    
    
    Exercised in 2007
    
    
    OUTSTANDING, JUNE 30, 2007
    
    
    44,917,899
    
    
    $
    0.101
    
    
    $
    970,368
    
 June 302007Raw material/WIP
    
    $
    346,401Work in process
    
    
    259,517Finished goods
    
    
    172,909778,827Less: Reserve for obsolescence
    
    
    (350,000
    )$
    428,827
   June 302007Computers
    
    $
    364,197Office furniture and fixtures
    
    
    583,497Machinery and equipment
    
    
    2,631,5493,579,243Less: Accumulated depreciation
    
    
    (3,233,612
    )$
    345,631




---



##### Table of Contents



June 302007Accounts payable  trade creditors
    
    $
    729,807Accounts payable  legal and professional
    
    
    991,967Accrued expenses
    
    
    184,744Accrued compensation
    
    
    2,034,398Accrued interest payable
    
    
    136,863Total accounts payable & accrued expenses
    
    $
    4,077,779
     Opening balance per January 1st, 2007
    
    $
    1,139,975Applied against shipments
    
    
    23,125Ending balance per June 30, 2007
    
    $
    1,116,850
  st st
  June 302007Notes payable with interest at 8%
due and demandable on December 31, 2007
    
    $
    148,204
   st st




---



##### Table of Contents



June 302007Notes payable to officer on demand
bearing interest rate of 8%, unsecured
    
    $
    926,408




---



##### Table of Contents








---



##### Table of Contents








---



##### Table of Contents








---



##### Table of Contents



1.
    
    the shares of Common Stock issuable upon conversion of any principal or interest due
under any notes issued in connection with any of the Whitebox financings;2.
    
    the shares of Common Stock issued in connection with any Whitebox financings;3.
    
    the shares of Common Stock issuable upon exercise of any warrants issued in connection
with any Whitebox financings; and4.
    
    the shares of Common Stock issuable upon conversion of principal or interest due under
the note issued to Synapse Capital, LLC in connection with the settlement of the
shareholder litigation.




---



##### Table of Contents



plus
 plus
  June 302007Whitebox I
    
    $
    6,550,000Whitebox II
    
    
    3,000,000Whitebox III
    
    
    7,000,000Idylwood Partners LLP
    
    
    750,000Whitebox V
    
    
    1,500,000Whitebox VI
    
    
    1,500,000Synapse settlement note
    
    
    400,000Whitebox VII
    
    
    550,000$
    21,250,000Debt issue costs
    
    
    (346,998
    )Beneficial conversion feature
    
    
    (1,263,884
    )$
    19,639,117Classified as current liability
    
    $
    2,253,717Classified as long term liabilty
    
    $
    17,385,400




---



##### Table of Contents



Intrinsic
    
    
    Intrinsic
    
    
    IntrinsicConversion
    
    
    Conversion
    
    
    value per
    
    
    value per
    
    
    value pershares
    
    
    price
    
    
    December
    
    
    end March
    
    
    end JuneWhitebox I
    
    
    43,666,667
    
    
    $
    0.1500
    
    
    $
    
    
    
    $Whitebox II
    
    
    20,000,000
    
    
    
    0.1500Whitebox III
    
    
    46,666,667
    
    
    
    0.1500Idylwood
    
    
    15,151,515
    
    
    
    0.0495
    
    
    
    7,576
    
    
    
    310,606
    
    
    
    340,909Whitebox V
    
    
    33,333,333
    
    
    
    0.0450
    
    
    
    166,667
    
    
    
    833,333
    
    
    
    900,000Whitebox VI
    
    
    33,333,333
    
    
    
    0.0450
    
    
    
    
    
    
    
    833,333
    
    
    
    900,000Synapse
    
    
    2,666,667
    
    
    
    0.1500194,818,182
    
    
    
    
    
    
    $
    174,242
    
    
    $
    1,977,273
    
    
    $
    2,140,909
   
 2nd
  nd




---



##### Table of Contents



2nd
   Remaining
    
    
    AggegrateLife in
    
    
    IntrinsicTotal
    
    
    Price
    
    
    years
    
    
    ValueWarrants issued in 2004
    
    
    6,311,951
    
    
    $
    0.6259
    
    
    
    1.8
    
    
    $Warrants Fusion
    
    
    1,220,565
    
    
    
    0.4464
    
    
    
    2.8Warrants Whitebox I
    
    
    14,423,512
    
    
    
    0.4541
    
    
    
    2.2Warrants Whitebox II
    
    
    1,666,667
    
    
    
    0.4500
    
    
    
    2.7Warrants Whitebox III
    
    
    1,609,197
    
    
    
    0.4500
    
    
    
    3.2Warrants Whitebox IV
    
    
    10,400,000
    
    
    
    0.0913
    
    
    
    4.5Cancelled in 2007
    
    
    
    
    
    
    
    
    
    
    Exercised in 2007
    
    
    
    
    
    
    
    
    
    
    OUTSTANDING, JUNE 2007
    
    
    35,631,891
    
    
    $
    0.3780
    
    
    
    2.9
    
    
    $
    
    
    Table of Contents   
  Millenium Litigation
  Shareholder Litigation
  Patent Infringement Litigation
        Table of Contents  1.
    
    The payment of principal and any then unpaid accrued interest on the
Whitebox I, Whitebox II and Whitebox III notes was extended from July 1, 2007 until
July 1, 2009;2.
    
    The payment of interest amounts due under the Whitebox I, Whitebox
II, Whitebox III, Whitebox V, and Whitebox VI notes may be paid in cash or by
issuance of a note in substantially the same form as the notes for the applicable
financing;3.
    
    The conversion rate at which the Whitebox I, Whitebox II and Whitebox III
notes may, at the election of the Whitebox affiliates, be converted into shares of
the Companys Common Stock shall be changed form $0.15 to $0.08; and4.
    
    The Company shall increase the outstanding principal amount of each
Whitebox I, Whitebox II, and Whitebox III notes by three percent (3%) as payment for
the note extension.
   plus
    Table of Contents  plus
   plus
 plus
 
 Item 2.
    Table of Contents  Table of Contents
    Table of Contents  
    Table of Contents  Financial Condition and Results of Operations for the three and six month periods ended June 30,
2007 compared to three and six month periods ended June 30, 2006
    Table of Contents  
    Table of Contents  Interest expenses.
 Three months
    
    
    Three months
    
    
    Year to date
    
    
    Year to date2007
    
    
    2006
    
    
    2007
    
    
    2006Note payable related
party in Euros
    
    $
    3,057
    
    
    $
    2,580
    
    
    $
    5,972
    
    
    $
    5,047Note payable officer
    
    
    18,528
    
    
    
    17,156
    
    
    
    37,056
    
    
    
    34,311Whitebox I
    
    
    196,500
    
    
    
    196,500
    
    
    
    393,000
    
    
    
    393,000Fusion
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    11,971WhiteboxII
    
    
    90,000
    
    
    
    60,000
    
    
    
    180,000
    
    
    
    120,000Whitebox III
    
    
    140,000
    
    
    
    140,000
    
    
    
    280,000
    
    
    
    280,000Idylwood Partners L.P.
    
    
    15,000
    
    
    
    10,500
    
    
    
    30,000
    
    
    
    10,500Whitebox IV
    
    
    
    
    
    
    2,778
    
    
    
    
    
    
    
    2,778Whitebox V
    
    
    30,000
    
    
    
    
    
    
    
    60,000
    
    
    
    Whitebox VI
    
    
    30,000
    
    
    
    
    
    
    
    38,333Synapse
    
    
    2,667
    
    
    
    
    
    
    
    2,667Whitebox VII
    
    
    6,034
    
    
    
    
    
    
    
    6,034Other
    
    
    0
    
    
    
    72
    
    
    
    0
    
    
    
    16,071$
    531,786
    
    
    $
    429,585
    
    
    $
    1,033,062
    
    
    $
    873,678Beneficial conversion
amortizationWhitebox I
    
    $
    291,377
    
    
    $
    291,377
    
    
    $
    582,754
    
    
    $
    582,755Fusion
    
    
    
    
    
    
    0
    
    
    
    
    
    
    
    144,153Whitebox II
    
    
    33,938
    
    
    
    33,938
    
    
    
    67,876
    
    
    
    67,876Repricing warrants
Whitebox II
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    41,362Whitebox III
    
    
    148,015
    
    
    
    122,762
    
    
    
    289,267
    
    
    
    239,915Repricing warrants
Whitebox III
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    92,520Idylwood Partners L.P.
    
    
    13,889
    
    
    
    
    
    
    
    34,722
    
    
    
    Whitebox V
    
    
    93,438
    
    
    
    
    
    
    
    175,987
    
    
    
    Total conversion
feature expense
    
    $
    580,657
    
    
    $
    448,077
    
    
    $
    1,150,606
    
    
    $
    1,168,581Total interest and
conversion expenses
    
    $
    1,112,442
    
    
    $
    877,661
    
    
    $
    2,183,667
    
    
    $
    2,042,259
    
 ITEM 3
    Table of Contents    Changes in Internal Controls over Financial Reporting.
   
 PART II: OTHER INFORMATION
 
 ITEM 1
 Millenium Litigation
  Shareholder Litigaiton
      Table of Contents    Patent Infringement Litigation




---



##### Table of Contents



ITEM 2
 th
 
 ITEM 3
  
 ITEM 4
  
 ITEM 5
  
 ITEM 6
 (a)
    
    Exhibits
 3.1
    
    Certificate of Incorporation13.2
    
    Certificate of Amendment to Certificate of Incorporation23.3
    
    Certificate of Amendment to Certificate of Incorporation73.4
    
    Certificate of Merger73.5
    
    Bylaws74.1
    
    Form of Common Stock Certificate110.1
    
    Sutura Inc. 2001 Stock Option Plan710.2
    
    Sutura Inc. 1999 Stock Option Plan710.3
    
    Employment Agreement with Egbert Ratering710.4
    
    Employment Agreement with Anthony Nobles710.5
    
    Sutura Inc. 2006 Stock Option Plan710.6
    
    Lease for Fountain Valley Location710.7
    
    Sucor License Agreement710.8
    
    Sterilis License Agreement7




---



##### Table of Contents



10.9
    
    Option and Distribution Agreement with Getz Bros. & Co., Inc., dated September 20, 2002710.10
    
    Convertible Promissory Note in Favor of Getz Bros. & Co., Inc., dated September 20, 2002710.11
    
    Purchase Agreement, dated as of September 17, 2004 by and between Sutura, Inc. and certain other parties thereto.310.12
    
    Purchase Agreement, dated as of March 24, 2005 by and between Sutura, Inc. and certain other parties thereto.310.13
    
    Form of Secured Convertible Promissory Note, dated September 17, 2004.310.14
    
    Form of Secured Convertible Promissory Note dated March 24, 2005.310.15
    
    Form of Warrant, dated September 17, 2004.310.16
    
    Form of Warrant dated, March 24, 2005.310.17
    
    Purchase Agreement, dated September 9, 2005 by and between Sutura, Inc. and certain other parties thereto.310.18
    
    Second Amended Security Agreement, dated September 9, 2005 by and between Sutura, Inc. and certain other parties thereto.310.19
    
    Second Amended Patent and Trademark Security Agreement, dated September 7, 2005 by and between Sutura, Inc. and certain other
parties thereto.310.20
    
    Second Amended Registration Rights Agreement, dated September 7, 2005 by and between Sutura, Inc. and certain other parties
thereto.310.21
    
    Form of Secured Convertible Promissory Note, dated September 7, 2005.310.22
    
    Form of Warrant dated September 7, 2004.3




---



##### Table of Contents



10.23
    
    Amendment to Secured Convertible Promissory Notes and Warrants, dated September 7, 2005 by and between Sutura, Inc. and certain
other parties thereto.310.24
    
    Amendment to Secured Convertible Promissory Notes and Warrants, dated June 30, 2006 by and between Sutura, Inc. and certain other
parties thereto.410.25
    
    Agreement and Plan of Merger dated November 22, 2004.510.26
    
    Distributor Agreement with Getz Bros & Co., Inc. dated September 20, 2002. 710.27
    
    Distribution Agreement with The Lifemed Group, Inc. dated January 16, 2006.710.28
    
    Form of Secured Convertible Promissory Note, dated June 7, 2006.810.29
    
    Third Amended Security Agreement, dated June 7, 2006, by and between Sutura, Inc., and certain other parties thereto.810.30
    
    Third Amended Patent and Trademark Security Agreement, dated June 7, 2006, by and between Sutura, Inc., and certain other parties
thereto.810.31
    
    Form of Secured Convertible Promissory Note, dated June 28, 2006.910.32
    
    Fourth Amended Security Agreement, dated June 28, 2006, by and between Sutura, Inc., and certain other parties thereto.910.33
    
    Fourth Amended Patent and Trademark Security Agreement, dated June 28, 2006, by and between Sutura, Inc., and certain other
parties thereto.910.34
    
    Securities Purchase Agreement dated, August 25, 2006, by and between Sutura, Inc., and certain other parties thereto.1010.35
    
    Third Amended Registration Rights Agreement, dated August 25, 2006, by and between Sutura, Inc., and certain other parties
thereto.1010.36
    
    Side Agreement, dated August 25, 2006, by and between Sutura, Inc., and certain parties thereto.1010.37
    
    Form of Warrant, dated August 25, 2006.1010.38
    
    Purchase Agreement, dated December 13, 2006.1110.39
    
    Form of Secured Convertible Promissory Note, dated December 13, 2006.1110.40
    
    Fourth Amended Security Agreement, dated December 13, 2006, by and between Sutura, Inc. and certain other parties
thereto.1110.41
    
    Fourth Amended Patent and Trademark Security Agreement, dated December 13, 2006, by and between Sutura, Inc., and certain other
parties thereto.1110.42
    
    Fourth Amended Registration Rights Agreement, dated December 13, 2006, by and between Sutura, Inc., and certain other parties
thereto.1110.43
    
    Form of Unsecured Promissory Note, dated May 18, 2006.1210.44
    
    Form of Unsecured Promissory Note, dated June 13, 2006.1310.45
    
    Settlement Agreement and Release.10.46
    
    Secured Convertible Promissory Note, dated June 1, 2007.




---



##### Table of Contents



10.47
    
    Fifth Amended Patent and Trademark Security Agreement, dated June 1, 2007, by and between Sutura, Inc., and certain other parties
thereto.10.48
    
    Fifth Amended Security Agreement, dated June 1, 2007, by and between Sutura, Inc. and certain other parties thereto.10.49
    
    Fifth Amended Registration Rights Agreement, dated June 1, 2007, by and between Sutura, Inc., and certain other parties thereto14.1
    
    Code of ethics for the Board of Directors.614.2
    
    Code of ethics for Executive Officers.631.1
    
    Certification of the Chief Executive Officer of Sutura, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.31.2
    
    Certification of the Chief Financial Officer of Sutura, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1
    
    Certification of the Chief Executive Officer and Chief Financial Officer of
Sutura, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


|   |  |                                                                                                                                 
|-- |  | --------------------------------------------------------------------------------------------------------------------------------
|1  |  | Previously filed as part of the Form 10-KSB filed in May 1995 and amendments thereto which are hereby incorporated by reference.
|  
|2  |  | Previously filed as part of the Form 10-KSB for the period ending December 31, 2001.                                            
|  
|3  |  | Previously filed as an exhibit to Form 8-K, filed on September 13, 2005.                                                        
|  
|4  |  | Previously filed as an exhibit to Form 8-K filed on June 30, 2006.                                                              
|  
|5  |  | Previously filed as an exhibit to Form 8-K filed on December 1, 2004.                                                           
|  
|6  |  | Previously filed as part of the Form 10-KSB for the period ending December 31, 2003.                                            
|  
|7  |  | Previously filed as part of the Form 10-KSB for the period ending December 31, 2005.                                            
|  
|8  |  | Previously filed as an exhibit to Form 8-K filed on June 13, 2006.                                                              
|  
|9  |  | Previously filed as an exhibit to Form 8-K filed on July 3, 2006.                                                               
|  
|10 |  | Previously filed as an Exhibit to Form 8-K filed on August 31, 2006.                                                            
|  
|11 |  | Previously filed as an Exhibit to Form 8-K filed on December 18, 2006.                                                          
|  
|12 |  | Previously filed as an Exhibit to Form 8-K filed on May 24, 2007.                                                               
|  
|13 |  | Previously filed as an Exhibit to Form 8-K filed on July 6, 2007.                                                               









---



##### Table of Contents













|                      |              |                                                      |  | 
|--------------------- | ------------ | ---------------------------------------------------- |  | 
|                      | SUTURA, INC. |                                                     
|                      | Registrant   |                                                     
|                     
|                     
|Date: August 20, 2007 | By:          | /s/ David Teckman                                    | 
|                      |              | David Teckman, President and Chief Executive Officer | 
|                      |              |                                                      | 
|                     
|                      |              |                                                     
|Date: August 20, 2007 | By:          | /s/ Richard Bjorkman                                 | 
|                      |              | Richard Bjorkman, Chief Financial Officer            | 
|                      |              |                                                      | 
|